Strides Pharma Inc. has voluntarily recalled 960 bottles of Tacrolimus Capsules USP (1mg), a prescription medication used to prevent organ rejection. This recall was initiated because the product failed to meet moisture limit specifications during stability testing. Consumers should contact their healthcare provider or pharmacist for guidance, as medication that does not meet quality standards may not perform as intended.
The failure to meet moisture limits can affect the stability and chemical integrity of the medication over time, potentially leading to reduced effectiveness of the drug.
Return unused product for a refund.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.